Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-003018

Chief Scientific Officer acquired 34,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kastelein Johannes Jacob Pieter Chief Scientific Officer 2025-01-07 Grant or award +34,000 34,000 D
Loading xslF345X05/ownership.xml…